NCT01711398View on ClinicalTrials.gov

Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

February 28, 2015

Conditions
All Solid Tumors
Interventions
DRUG

Drug

Trial Locations (3)

1000

Institut Jules Bordet, Brussels

21079

Centre Georges François Leclerc, Dijon

31300

Centre Claudius Regaud, Toulouse

Sponsors

Lead Sponsor

Elro Pharma
All Listed Sponsors
lead

Elro Pharma

INDUSTRY